YOU'RE INVITED: SUBSCRIBE TO PREMIUM TO JOIN

THE INSIDE STORY: What to expect next in the vaccination effort and how business is stepping in

We’re finally playing offense vs. COVID-19: More than 75 million Americans have received at least one dose of vaccine in the U.S., and some 2.5 million vaccinations are being administered every day.

What will the next stage of the vaccination effort look like? How is big business stepping in to assist with the effort? And what are the potential dangers lurking below the headlines?

Subscribe to Fortune Premium to access this roundtable conversation that will look ahead at the impact on public health, business, and the economy.

Save $72 a year

For $9/month, an annual Fortune premium subscription gives you access to subscriber webinars, exclusive list analysis, investment guides, weekly proprietary research, and unlimited articles.

Market insights from leading experts & news analysis that gives you an edge:

Karen Lynch got the big job at CVS. Now comes the big challenge: Vaccinate America

The new CVS Health chief is the highest-ranking female CEO ever to appear in the Fortune 500—just in time for the company’s most important mission yet.

Pregnant women aren’t typically included in clinical trials, but that’s changing with COVID

Having as many women as possible, while pregnant or after giving birth, receive vaccines will be critical to the goal of achieving herd immunity that protects everyone.

Where will vaccine passports actually take us?

"My vaccine will give me a sense of liberation, but it's unclear how free I'll really be."

The startup behind a COVID-19 vaccine gears up for an IPO

The company behind the AstraZeneca COVID-19 vaccine, Vaccitech, has raised $125 million in Series B funding in addition to $43 million in convertible notes.

This email was sent to [email protected]
Unsubscribe from these messages here.

Fortune Media (USA) Corporation
40 Fulton Street New York, NY 10038